Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • CDK
    (3)
  • GSK-3
    (1)
  • PKC
    (1)
  • Others
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (2)
Filter
Search Result
Results for "

cdk8-in-12

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    3
    TargetMol | All_Pathways
  • CDK8-IN-12
    T720482613307-67-6In house
    CDK8-IN-12 is a selective, potent and orally active inhibitor of CDK8 (Ki: 14 nM) and is an anti-cancer agent. CDK8-IN-12 inhibits GSK-3α, GSK-3β and PCK-θ with Ki of 13 nM, 4 nM and 109 nM respectively. CDK8-IN-12 showed anti-proliferative activity against MV4-11 cells.
    • $44
    In Stock
    Size
    QTY
  • CDK8-IN-7
    T623542415156-30-6
    CDK8-IN-7 (compound 12) is a potent and selective inhibitor of cyclin-dependent kinase 8 (CDK8), with a Kd of 3.5 nM, and has demonstrated potential for AML-cancer research.
    • $1,520
    6-8 weeks
    Size
    QTY
  • CDK8-IN-14
    T860312924193-12-2
    CDK8-IN-14 (compound 12) effectively inhibits CDK8, demonstrating an IC50 of 39.2 nM, and exhibits potent anti-AML cell proliferation effects, with a GC50 value of 0.02±0.01μM in MOLM-13 cells and 0.03±0.01μM in MV4-11 cells [1].
    • Inquiry Price
    10-14 weeks
    Size
    QTY